ArticleChild abuse & neglect2026
Glutaric aciduria type 1 as a mimicker of abusive head trauma in the era of newborn screening.
Article in Child abuse & neglect, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundGlutaric aciduria type 1 (GA1) is a cerebral organic aciduria which untreated may lead to metabolic crisis and the development of a complex movement disorder. In addition to the motor phenotype, early natural history studies reported a high incidence of spontaneous subdural hemorrhage (SDH). This has led to the inclusion of GA1 in the differential diagnosis of isolated SDH concerning for abusive head trauma and the widespread use of costly biochemical and molecular testing in this population. Contemporary newborn screening (NBS) methods enable presymptomatic detection of GA1, although false negatives have been reported.
objectiveIn this single-center, 20-year retrospective review, we aimed to estimate the false negative rate of NBS for GA1 as well as the incidence of SDH as the presenting finding of GA1 in the post-NBS era. PARTICIPANTS AND
settingGA1 patients referred to the Texas Children's Hospital Metabolic Genetics Clinic from 2006 to 2025.
methodsDemographic data, NBS results, confirmatory biochemical and molecular studies, and neuroimaging reports were collected by retrospective chart review from all subjects when available.
resultsAll 20 GA1 patients referred to our center were ascertained by NBS including two patients with a "low-excretor" biochemical phenotype. Classic neuroradiographic findings were present in most patients. SDH was detected incidentally in a single patient who demonstrated additional characteristic neuroimaging findings.
conclusionsEvaluation for GA1 in patients presenting with isolated SDH in the setting of a negative NBS is likely to be of limited value - especially in the absence of additional suggestive neuroradiological features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.